Oncology Head and Neck Cancers

Head and neck cancers are a group of cancers that start in the mouth, throat, nose, salivary glands, and lymph nodes in the neck. These types of cancers are often treated by radiation therapy, surgery, or a combination of both. The field of oncology for head and neck cancers is constantly evolving with new research and treatments. One area of focus in hematology and oncology research for head and neck cancers is the study of targeted therapies. These therapies use drugs or other substances that can target specific molecules in cancer cells that help them grow and divide. By targeting these molecules, targeted therapies can slow or stop the growth of cancer cells. Another area of research is the use of immunotherapy in the treatment of head and neck cancers. Immunotherapy is a type of cancer treatment that uses the body's own immune system to fight cancer. Immunotherapy drugs can help boost the immune system's ability to recognize and attack cancer cells. Additionally, researchers are studying the use of precision medicine in the treatment of head and neck cancers. Precision medicine involves using genetic and molecular information about a person's cancer to help tailor their treatment plan. By understanding the specific genetic mutations and proteins present in a person's cancer cells, doctors can prescribe treatments that are more likely to be effective. By continuing to study and develop new treatments for head and neck cancers, researchers in hematology and oncology are working to improve the survival rates and quality of life for people with these types of cancers.